Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -30,594 | -20,838 | -9,012 | -21,102 |
| Depreciation Amortization | 1,555 | 970 | 458 | 1,553 |
| Accounts receivable | -6,523 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 953 | 234 | 355 | N/A |
| Other Working Capital | -10,477 | -4,309 | -6,056 | -5,095 |
| Other Operating Activity | 6,275 | 179 | -199 | 475 |
| Operating Cash Flow | $-38,811 | $-23,764 | $-14,454 | $-24,169 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -4,392 | -1,747 | -619 | -5,515 |
| Net Acquisitions | -1,400 | N/A | N/A | 0 |
| Investing Cash Flow | $-5,792 | $-1,747 | $-619 | $-5,515 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 109 | 82 | 20 | N/A |
| Other Financing Activity | 109,260 | 87,970 | 0 | -937 |
| Financing Cash Flow | $109,369 | $88,052 | $20 | $-937 |
| Beginning Cash Position | 62,802 | 62,802 | 62,802 | 93,423 |
| End Cash Position | 127,568 | 125,343 | 47,749 | 62,802 |
| Net Cash Flow | $64,766 | $62,541 | $-15,053 | $-30,621 |
| Free Cash Flow | ||||
| Operating Cash Flow | -38,811 | -23,764 | -14,454 | -24,169 |
| Capital Expenditure | -4,407 | -1,747 | -619 | N/A |
| Free Cash Flow | -43,218 | -25,511 | -15,073 | -24,169 |